Page last updated: 2024-08-26

imipenem, anhydrous and Autoimmune Diabetes

imipenem, anhydrous has been researched along with Autoimmune Diabetes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benbrika, S; Boukari, L; Fain, O; Kettaneh, A; Letellier, E; Stirnemann, J; Thomas, M1
Gibbons, GW; Grayson, ML; Karchmer, AW; McKinnon, PS; Paladino, JA1

Trials

1 trial(s) available for imipenem, anhydrous and Autoimmune Diabetes

ArticleYear
Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1

    Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cost-Benefit Analysis; Diabetes Mellitus, Type 1; Drug Costs; Drug Therapy; Drug Therapy, Combination; Foot Diseases; Hospital Costs; Hospitalization; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Penicillins; Protease Inhibitors; Sulbactam; Thienamycins

1997

Other Studies

1 other study(ies) available for imipenem, anhydrous and Autoimmune Diabetes

ArticleYear
[A case of yersiniasis with multiple liver abscesses].
    La Revue de medecine interne, 2005, Volume: 26, Issue:2

    Topics: Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hemochromatosis; Hepatitis; Humans; Imipenem; Liver Abscess; Male; Middle Aged; Ofloxacin; Radiography, Abdominal; Time Factors; Tomography, X-Ray Computed; Yersinia enterocolitica; Yersinia Infections

2005